SG11202105455RA - Elacestrant in combination with abemaciclib in women with breast cancer - Google Patents
Elacestrant in combination with abemaciclib in women with breast cancerInfo
- Publication number
- SG11202105455RA SG11202105455RA SG11202105455RA SG11202105455RA SG11202105455RA SG 11202105455R A SG11202105455R A SG 11202105455RA SG 11202105455R A SG11202105455R A SG 11202105455RA SG 11202105455R A SG11202105455R A SG 11202105455RA SG 11202105455R A SG11202105455R A SG 11202105455RA
- Authority
- SG
- Singapore
- Prior art keywords
- patient
- abemaciclib
- administered
- dose
- day
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862773960P | 2018-11-30 | 2018-11-30 | |
| PCT/US2019/063239 WO2020112765A1 (en) | 2018-11-30 | 2019-11-26 | Elacestrant in combination with abemaciclib in women with breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105455RA true SG11202105455RA (en) | 2021-06-29 |
Family
ID=68966023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105455RA SG11202105455RA (en) | 2018-11-30 | 2019-11-26 | Elacestrant in combination with abemaciclib in women with breast cancer |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20220117963A1 (enExample) |
| EP (1) | EP3886826A1 (enExample) |
| JP (2) | JP2022509262A (enExample) |
| KR (1) | KR20210097170A (enExample) |
| CN (1) | CN113164415A (enExample) |
| AU (1) | AU2019388900B2 (enExample) |
| BR (1) | BR112021010169A2 (enExample) |
| CA (1) | CA3120368A1 (enExample) |
| EA (1) | EA202191165A1 (enExample) |
| IL (1) | IL283502A (enExample) |
| JO (1) | JOP20210125A1 (enExample) |
| MA (1) | MA54293A (enExample) |
| MX (1) | MX2021005876A (enExample) |
| MY (1) | MY209833A (enExample) |
| PH (1) | PH12021551235A1 (enExample) |
| SG (1) | SG11202105455RA (enExample) |
| UA (1) | UA129403C2 (enExample) |
| WO (1) | WO2020112765A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3847157T3 (da) | 2018-09-07 | 2022-08-08 | Sanofi Sa | Fremgangsmåde til fremstilling af methyl-[6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylat] og salt deraf |
| WO2021063967A1 (en) | 2019-10-01 | 2021-04-08 | Sanofi | Novel substituted 6,7-dihydro-5h-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof |
| CA3160897A1 (en) | 2019-12-09 | 2021-06-17 | Sanofi | Crystalline form of a 7h-benzo[7]annulene-2-carboxylic acid derivative |
| TW202146007A (zh) | 2020-02-27 | 2021-12-16 | 法商賽諾菲公司 | 包含阿培利司（ａｌｐｅｌｉｓｉｂ）與６－（２，４－二氯苯基）－５－［４－［（３ｓ）－１－（３－氟丙基）吡咯啶－３－基］氧苯基］－８，９－二氫－７ｈ－苯并［７］輪烯－２－羧酸之組合 |
| IL302153B1 (en) | 2020-10-19 | 2026-07-01 | Sanofi Sa | 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR THERAPEUTIC USES |
| IL302152B1 (en) | 2020-10-19 | 2026-07-01 | Sanofi Sa | 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR THERAPEUTIC USES |
| WO2022106711A1 (en) * | 2020-11-23 | 2022-05-27 | Sanofi | Combination comprising abemaciclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid |
| JP7846700B2 (ja) * | 2021-02-16 | 2026-04-15 | ジェネンテック， インコーポレイテッド | Ｇｄｃ－９５４５とアベマシクリブ又はリボシクリブとを含む併用療法を使用する乳がんの治療 |
| CN114146182A (zh) * | 2021-11-12 | 2022-03-08 | 深圳大学 | Cdk4/6抑制剂与铂类化疗药物在制备治疗肿瘤的药物中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX384605B (es) * | 2015-04-29 | 2025-03-14 | Radius Pharmaceuticals Inc | Combinación de palbociclib y rad1901 para usarse en el tratamiento de cáncer de mama en un sujeto con cáncer positivo a receptor de estrógeno. |
| WO2017160990A1 (en) * | 2016-03-15 | 2017-09-21 | Merrimack Pharmaceuticals, Inc. | Methods for treating er+, her2-, hrg+ breast cancer using combination therapies comprising an anti-erbb3 antibody |
| WO2018017410A1 (en) * | 2016-07-22 | 2018-01-25 | Eli Lilly And Company | Combination therapy of abemaciclib and a pi3 kinase/mtor dual inhibitor for use in the treatment of breast cancer |
-
2019
- 2019-11-26 WO PCT/US2019/063239 patent/WO2020112765A1/en not_active Ceased
- 2019-11-26 MA MA054293A patent/MA54293A/fr unknown
- 2019-11-26 SG SG11202105455RA patent/SG11202105455RA/en unknown
- 2019-11-26 JO JOP/2021/0125A patent/JOP20210125A1/ar unknown
- 2019-11-26 CN CN201980079089.6A patent/CN113164415A/zh active Pending
- 2019-11-26 EA EA202191165A patent/EA202191165A1/ru unknown
- 2019-11-26 BR BR112021010169-1A patent/BR112021010169A2/pt unknown
- 2019-11-26 EP EP19824087.1A patent/EP3886826A1/en active Pending
- 2019-11-26 MY MYPI2021002887A patent/MY209833A/en unknown
- 2019-11-26 MX MX2021005876A patent/MX2021005876A/es unknown
- 2019-11-26 UA UAA202102817A patent/UA129403C2/uk unknown
- 2019-11-26 AU AU2019388900A patent/AU2019388900B2/en active Active
- 2019-11-26 JP JP2021530913A patent/JP2022509262A/ja active Pending
- 2019-11-26 KR KR1020217020321A patent/KR20210097170A/ko not_active Ceased
- 2019-11-26 US US17/298,198 patent/US20220117963A1/en not_active Abandoned
- 2019-11-26 CA CA3120368A patent/CA3120368A1/en active Pending
-
2021
- 2021-05-27 IL IL283502A patent/IL283502A/en unknown
- 2021-05-28 PH PH12021551235A patent/PH12021551235A1/en unknown
-
2025
- 2025-03-25 JP JP2025050208A patent/JP2025094216A/ja active Pending
- 2025-05-02 US US19/197,091 patent/US20250268899A1/en not_active Abandoned
- 2025-09-24 US US19/338,117 patent/US20260014153A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250268899A1 (en) | 2025-08-28 |
| IL283502A (en) | 2021-07-29 |
| JP2022509262A (ja) | 2022-01-20 |
| CA3120368A1 (en) | 2020-06-04 |
| JOP20210125A1 (ar) | 2019-11-26 |
| KR20210097170A (ko) | 2021-08-06 |
| MA54293A (fr) | 2021-10-06 |
| WO2020112765A1 (en) | 2020-06-04 |
| MY209833A (en) | 2025-08-07 |
| BR112021010169A2 (pt) | 2021-08-17 |
| AU2019388900B2 (en) | 2025-09-04 |
| MX2021005876A (es) | 2021-07-16 |
| US20260014153A1 (en) | 2026-01-15 |
| UA129403C2 (uk) | 2025-04-16 |
| JP2025094216A (ja) | 2025-06-24 |
| CN113164415A (zh) | 2021-07-23 |
| EA202191165A1 (ru) | 2021-09-21 |
| US20220117963A1 (en) | 2022-04-21 |
| AU2019388900A1 (en) | 2021-06-10 |
| EP3886826A1 (en) | 2021-10-06 |
| PH12021551235A1 (en) | 2021-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283502A (en) | Alactestrant in combination with abmicislib in women with breast cancer | |
| SG11202104356VA (en) | Bt1718 for use in treating cancer | |
| ZA201801036B (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | |
| SG10202005950XA (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | |
| SI3624837T1 (sl) | Protitelesa proti FGFR2 v kombinaciji s kemoterapevtskimi sredstvi pri zdravljenju raka | |
| LT3474841T (lt) | Ar+ krūties vėžio gydymo būdai | |
| EP3134115A4 (en) | Methods and compositions for treating metastatic breast cancer and other cancers in the brain | |
| SG10202008070XA (en) | Uterine cancer treatments | |
| PL3756493T3 (pl) | Odzież i biustonosz | |
| ZA202102740B (en) | Anti-liv1 immune cell cancer therapy | |
| ZA202102745B (en) | Anti-ptk7 immune cell cancer therapy | |
| ZA202000851B (en) | Antibodies useful in cancer diagnosis | |
| EP3353554A4 (en) | BIOMARKERS FOR THE DETECTION OF BREAST CANCER IN WOMEN WITH DENSE BREASTS | |
| SG11202008193XA (en) | Brassiere | |
| PL3253208T3 (pl) | Terapie kombinowane do zastosowania w leczeniu nowotworu piersi | |
| GB2579328B (en) | Breast cancer detection | |
| GB2577116B (en) | Brassiere | |
| IL259241A (en) | Combination of tumor characteristics with breast cancer index | |
| GB201800733D0 (en) | Cancer | |
| SG11202007005UA (en) | Use of crassocephalum rabens extract in the treatment of breast cancer | |
| IL262143A (en) | Improvements in cancer treatment | |
| GB201814487D0 (en) | Cancer | |
| SG11202105276TA (en) | Oligo-benzamide analogs and their use in cancer treatment | |
| GB201614955D0 (en) | Brassiere with breast seperator | |
| HK40062951A (en) | Elacestrant in combination with abemaciclib in women with breast cancer |